DnB Asset Management
VERA icon

DnB Asset Management’s Vera Therapeutics VERA Stock Holding History

DnB Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,485
Closed -$204K – 776
2025
Q1 		$204K Buy
+8,485
New +$273K ﹤0.01% 706

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

DnB Asset Management's VERA Position: Q2 2025 in Review

DnB Asset Management sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 8,485 shares — an estimated $204K sold.

DnB Asset Management first reported a position in VERA in Q1 2025 and held it in 1 quarter. The position peaked at $204K in Q1 2025. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

  • DnB Asset Management reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
  • DnB Asset Management sold 8,485 Vera Therapeutics shares in Q2 2025, an estimated $204K.
  • DnB Asset Management first reported a position in Vera Therapeutics in Q1 2025 and held it in 1 quarter.
  • DnB Asset Management's Vera Therapeutics position peaked at $204K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on DnB Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.